CKD Bio Corp. (KRX:063160)
South Korea
· Delayed Price · Currency is KRW 22,050
-300 (-1.34%)
At close: May 9, 2025, 3:30 PM KST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Drug Substance | 133.93B |
Log In |
Log In |
Log In |
Log In |
| Drug Substance Growth | 7.07% |
Log In |
Log In |
Log In |
Log In |
| Probiotics | 19.06B |
Log In |
Log In |
Log In |
Log In |
| Probiotics Growth | -23.72% |
Log In |
Log In |
Log In |
Log In |
| Botulinum Toxin | 7.36B |
Log In |
Log In |
Log In |
Log In |
| Botulinum Toxin Growth | 23.32% |
Log In |
Log In |
Log In |
Log In |
| Pharmaceutical Ingredients and Health Functional Foods | - |
Log In |
Log In |
Log In |
Log In |
| Pharmaceutical Ingredients and Health Functional Foods Growth | - |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Europe | 56.28B |
Log In |
Log In |
Log In |
Log In |
| Europe Growth | 50.62% |
Log In |
Log In |
Log In |
Log In |
| Asia | 37.64B |
Log In |
Log In |
Log In |
Log In |
| Asia Growth | -22.58% |
Log In |
Log In |
Log In |
Log In |
| South Korea | 37.18B |
Log In |
Log In |
Log In |
Log In |
| South Korea Growth | -19.04% |
Log In |
Log In |
Log In |
Log In |
| Middle East | 12.90B |
Log In |
Log In |
Log In |
Log In |
| Middle East Growth | 89.94% |
Log In |
Log In |
Log In |
Log In |
| Other | 16.35B |
Log In |
Log In |
Log In |
Log In |
| Other Growth | -5.71% |
Log In |
Log In |
Log In |
Log In |